CN107149132A - 低钾海带粉排钠盐及制备方法和应用 - Google Patents
低钾海带粉排钠盐及制备方法和应用 Download PDFInfo
- Publication number
- CN107149132A CN107149132A CN201710297972.5A CN201710297972A CN107149132A CN 107149132 A CN107149132 A CN 107149132A CN 201710297972 A CN201710297972 A CN 201710297972A CN 107149132 A CN107149132 A CN 107149132A
- Authority
- CN
- China
- Prior art keywords
- powder
- potassium
- kelp powder
- low
- low potassium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000843 powder Substances 0.000 title claims abstract description 121
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 title claims abstract description 112
- 239000011591 potassium Substances 0.000 title claims abstract description 112
- 229910052700 potassium Inorganic materials 0.000 title claims abstract description 112
- 241000512259 Ascophyllum nodosum Species 0.000 title claims abstract description 89
- 159000000000 sodium salts Chemical class 0.000 title claims abstract description 19
- 238000002360 preparation method Methods 0.000 title claims abstract description 16
- 235000010408 potassium alginate Nutrition 0.000 claims abstract description 25
- 229910052785 arsenic Inorganic materials 0.000 claims abstract description 12
- RQNWIZPPADIBDY-UHFFFAOYSA-N arsenic atom Chemical compound [As] RQNWIZPPADIBDY-UHFFFAOYSA-N 0.000 claims abstract description 12
- 238000000108 ultra-filtration Methods 0.000 claims abstract description 11
- 230000004913 activation Effects 0.000 claims abstract description 9
- 238000001914 filtration Methods 0.000 claims abstract description 9
- 239000002253 acid Substances 0.000 claims abstract description 8
- 235000013361 beverage Nutrition 0.000 claims abstract description 6
- 238000004332 deodorization Methods 0.000 claims abstract description 6
- 102000004190 Enzymes Human genes 0.000 claims abstract description 5
- 108090000790 Enzymes Proteins 0.000 claims abstract description 5
- 101710180012 Protease 7 Proteins 0.000 claims abstract description 5
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims abstract description 4
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims abstract description 4
- 239000011575 calcium Substances 0.000 claims abstract description 4
- 229910052791 calcium Inorganic materials 0.000 claims abstract description 4
- 229910001385 heavy metal Inorganic materials 0.000 claims abstract description 4
- 229910052740 iodine Inorganic materials 0.000 claims abstract description 4
- 239000011630 iodine Substances 0.000 claims abstract description 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 28
- 229910052708 sodium Inorganic materials 0.000 claims description 28
- 239000011734 sodium Substances 0.000 claims description 28
- 235000013305 food Nutrition 0.000 claims description 24
- 239000000737 potassium alginate Substances 0.000 claims description 22
- MZYRDLHIWXQJCQ-YZOKENDUSA-L potassium alginate Chemical compound [K+].[K+].O1[C@@H](C([O-])=O)[C@@H](OC)[C@H](O)[C@H](O)[C@@H]1O[C@@H]1[C@@H](C([O-])=O)O[C@@H](O)[C@@H](O)[C@H]1O MZYRDLHIWXQJCQ-YZOKENDUSA-L 0.000 claims description 22
- 239000000047 product Substances 0.000 claims description 20
- 150000003839 salts Chemical class 0.000 claims description 16
- 235000013312 flour Nutrition 0.000 claims description 15
- 240000002900 Arthrospira platensis Species 0.000 claims description 12
- 235000016425 Arthrospira platensis Nutrition 0.000 claims description 12
- 229940082787 spirulina Drugs 0.000 claims description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 12
- 239000003795 chemical substances by application Substances 0.000 claims description 10
- 239000000706 filtrate Substances 0.000 claims description 8
- 230000008014 freezing Effects 0.000 claims description 5
- 238000007710 freezing Methods 0.000 claims description 5
- 229920002472 Starch Polymers 0.000 claims description 4
- 239000000796 flavoring agent Substances 0.000 claims description 4
- 235000019634 flavors Nutrition 0.000 claims description 4
- 239000012535 impurity Substances 0.000 claims description 4
- BITYAPCSNKJESK-UHFFFAOYSA-N potassiosodium Chemical compound [Na].[K] BITYAPCSNKJESK-UHFFFAOYSA-N 0.000 claims description 4
- 235000019698 starch Nutrition 0.000 claims description 4
- 239000008107 starch Substances 0.000 claims description 4
- 230000009967 tasteless effect Effects 0.000 claims description 4
- 235000013365 dairy product Nutrition 0.000 claims description 3
- 238000007654 immersion Methods 0.000 claims description 3
- 240000002853 Nelumbo nucifera Species 0.000 claims 6
- 235000006508 Nelumbo nucifera Nutrition 0.000 claims 6
- 240000008042 Zea mays Species 0.000 claims 4
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims 4
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims 4
- 235000005822 corn Nutrition 0.000 claims 4
- 235000017060 Arachis glabrata Nutrition 0.000 claims 3
- 244000105624 Arachis hypogaea Species 0.000 claims 3
- 235000010777 Arachis hypogaea Nutrition 0.000 claims 3
- 235000018262 Arachis monticola Nutrition 0.000 claims 3
- 235000006510 Nelumbo pentapetala Nutrition 0.000 claims 3
- 235000013336 milk Nutrition 0.000 claims 3
- 239000008267 milk Substances 0.000 claims 3
- 210000004080 milk Anatomy 0.000 claims 3
- 235000020232 peanut Nutrition 0.000 claims 3
- 230000001954 sterilising effect Effects 0.000 claims 2
- 240000008620 Fagopyrum esculentum Species 0.000 claims 1
- 235000009419 Fagopyrum esculentum Nutrition 0.000 claims 1
- 235000021307 Triticum Nutrition 0.000 claims 1
- 244000098338 Triticum aestivum Species 0.000 claims 1
- 238000002386 leaching Methods 0.000 claims 1
- 235000014571 nuts Nutrition 0.000 claims 1
- 206010020772 Hypertension Diseases 0.000 abstract description 34
- 210000004369 blood Anatomy 0.000 abstract description 31
- 239000008280 blood Substances 0.000 abstract description 31
- 230000000694 effects Effects 0.000 abstract description 22
- 239000003814 drug Substances 0.000 abstract description 20
- 239000000463 material Substances 0.000 abstract description 12
- 208000001953 Hypotension Diseases 0.000 abstract description 4
- 239000007787 solid Substances 0.000 abstract description 4
- 208000021822 hypotensive Diseases 0.000 abstract description 3
- 230000001077 hypotensive effect Effects 0.000 abstract description 3
- 235000013373 food additive Nutrition 0.000 abstract description 2
- 239000002778 food additive Substances 0.000 abstract description 2
- 235000012041 food component Nutrition 0.000 abstract 1
- 239000005417 food ingredient Substances 0.000 abstract 1
- 239000002994 raw material Substances 0.000 abstract 1
- 230000036772 blood pressure Effects 0.000 description 31
- 230000002354 daily effect Effects 0.000 description 10
- 239000012528 membrane Substances 0.000 description 10
- 230000001631 hypertensive effect Effects 0.000 description 8
- 235000010443 alginic acid Nutrition 0.000 description 6
- 229920000615 alginic acid Polymers 0.000 description 6
- 230000003276 anti-hypertensive effect Effects 0.000 description 6
- 230000006837 decompression Effects 0.000 description 6
- 238000010586 diagram Methods 0.000 description 6
- 235000005911 diet Nutrition 0.000 description 6
- 230000037213 diet Effects 0.000 description 6
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 5
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 5
- 239000000783 alginic acid Substances 0.000 description 5
- 229960001126 alginic acid Drugs 0.000 description 5
- 150000004781 alginic acids Chemical class 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- 210000002216 heart Anatomy 0.000 description 5
- 238000001727 in vivo Methods 0.000 description 5
- 230000009467 reduction Effects 0.000 description 5
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- 230000033228 biological regulation Effects 0.000 description 4
- 210000004556 brain Anatomy 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 239000008103 glucose Substances 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 238000003860 storage Methods 0.000 description 4
- FKNQFGJONOIPTF-UHFFFAOYSA-N Sodium cation Chemical compound [Na+] FKNQFGJONOIPTF-UHFFFAOYSA-N 0.000 description 3
- 208000007536 Thrombosis Diseases 0.000 description 3
- 239000002220 antihypertensive agent Substances 0.000 description 3
- 229940127088 antihypertensive drug Drugs 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 238000005374 membrane filtration Methods 0.000 description 3
- 239000001103 potassium chloride Substances 0.000 description 3
- 235000011164 potassium chloride Nutrition 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 235000021023 sodium intake Nutrition 0.000 description 3
- 229910001415 sodium ion Inorganic materials 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 231100000331 toxic Toxicity 0.000 description 3
- 230000002588 toxic effect Effects 0.000 description 3
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 2
- 206010061623 Adverse drug reaction Diseases 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- 208000030453 Drug-Related Side Effects and Adverse reaction Diseases 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000002776 aggregation Effects 0.000 description 2
- 238000004220 aggregation Methods 0.000 description 2
- 206010003119 arrhythmia Diseases 0.000 description 2
- 230000006793 arrhythmia Effects 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 235000015895 biscuits Nutrition 0.000 description 2
- 230000036770 blood supply Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 238000007906 compression Methods 0.000 description 2
- 230000002526 effect on cardiovascular system Effects 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 235000013402 health food Nutrition 0.000 description 2
- 208000019622 heart disease Diseases 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 235000012149 noodles Nutrition 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229920002492 poly(sulfone) Polymers 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 235000020995 raw meat Nutrition 0.000 description 2
- 238000009877 rendering Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000000661 sodium alginate Substances 0.000 description 2
- 235000010413 sodium alginate Nutrition 0.000 description 2
- 229940005550 sodium alginate Drugs 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 230000035488 systolic blood pressure Effects 0.000 description 2
- 230000002792 vascular Effects 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- 229940127291 Calcium channel antagonist Drugs 0.000 description 1
- 208000006029 Cardiomegaly Diseases 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 108091006146 Channels Proteins 0.000 description 1
- JZUFKLXOESDKRF-UHFFFAOYSA-N Chlorothiazide Chemical group C1=C(Cl)C(S(=O)(=O)N)=CC2=C1NCNS2(=O)=O JZUFKLXOESDKRF-UHFFFAOYSA-N 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- AEMOLEFTQBMNLQ-VANFPWTGSA-N D-mannopyranuronic acid Chemical compound OC1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@@H]1O AEMOLEFTQBMNLQ-VANFPWTGSA-N 0.000 description 1
- 206010016322 Feeling abnormal Diseases 0.000 description 1
- 229920002430 Fibre-reinforced plastic Polymers 0.000 description 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 208000002682 Hyperkalemia Diseases 0.000 description 1
- 206010020710 Hyperphagia Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 206010061216 Infarction Diseases 0.000 description 1
- 208000010428 Muscle Weakness Diseases 0.000 description 1
- 206010064470 Muscle swelling Diseases 0.000 description 1
- 206010028372 Muscular weakness Diseases 0.000 description 1
- 206010031127 Orthostatic hypotension Diseases 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 239000002333 angiotensin II receptor antagonist Substances 0.000 description 1
- 229940125364 angiotensin receptor blocker Drugs 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 239000000480 calcium channel blocker Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 230000003130 cardiopathic effect Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 206010008118 cerebral infarction Diseases 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000005660 chlorination reaction Methods 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 238000010924 continuous production Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 229920006239 diacetate fiber Polymers 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 229940030606 diuretics Drugs 0.000 description 1
- 235000012489 doughnuts Nutrition 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 206010013663 drug dependence Diseases 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000011151 fibre-reinforced plastic Substances 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 210000004051 gastric juice Anatomy 0.000 description 1
- 238000003304 gavage Methods 0.000 description 1
- 239000003365 glass fiber Substances 0.000 description 1
- 239000002241 glass-ceramic Substances 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 230000007954 hypoxia Effects 0.000 description 1
- 230000007574 infarction Effects 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 230000000366 juvenile effect Effects 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 208000012866 low blood pressure Diseases 0.000 description 1
- 229940080286 lowsium Drugs 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000002464 muscle smooth vascular Anatomy 0.000 description 1
- 230000001473 noxious effect Effects 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 229940070017 potassium supplement Drugs 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 230000000306 recurrent effect Effects 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000011343 solid material Substances 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 208000011117 substance-related disease Diseases 0.000 description 1
- 210000003684 theca cell Anatomy 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/40—Table salts; Dietetic salt substitutes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L17/00—Food-from-the-sea products; Fish products; Fish meal; Fish-egg substitutes; Preparation or treatment thereof
- A23L17/60—Edible seaweed
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Marine Sciences & Fisheries (AREA)
- Zoology (AREA)
- Mycology (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710297972.5A CN107149132A (zh) | 2017-04-29 | 2017-04-29 | 低钾海带粉排钠盐及制备方法和应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710297972.5A CN107149132A (zh) | 2017-04-29 | 2017-04-29 | 低钾海带粉排钠盐及制备方法和应用 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN107149132A true CN107149132A (zh) | 2017-09-12 |
Family
ID=59792638
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710297972.5A Pending CN107149132A (zh) | 2017-04-29 | 2017-04-29 | 低钾海带粉排钠盐及制备方法和应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107149132A (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110419712A (zh) * | 2019-08-03 | 2019-11-08 | 深圳震乾坤生物科技有限公司 | 低钾海带粉调胃低钠盐及制备方法和应用 |
CN110810804A (zh) * | 2019-12-30 | 2020-02-21 | 好当家集团有限公司 | 一种海带生物盐的制备方法 |
CN113875782A (zh) * | 2021-10-14 | 2022-01-04 | 中兆科生物科技(深圳)有限公司 | 一种灭杀新冠病毒外用喷雾剂 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1380885A (zh) * | 1999-11-30 | 2002-11-20 | 大连雅威特生物工程有限公司 | 低分子量藻酸盐及其制备方法和用途 |
CN1597703A (zh) * | 2004-08-20 | 2005-03-23 | 赵波 | 低分子海藻酸钾及其应用 |
CN103739740A (zh) * | 2013-11-30 | 2014-04-23 | 青岛海之林生物科技开发有限公司 | 海藻酸钾的制造方法 |
CN104222999A (zh) * | 2014-09-26 | 2014-12-24 | 大连雅威特生物技术股份有限公司 | 一种新型低钠盐的组成、制备和用途 |
-
2017
- 2017-04-29 CN CN201710297972.5A patent/CN107149132A/zh active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1380885A (zh) * | 1999-11-30 | 2002-11-20 | 大连雅威特生物工程有限公司 | 低分子量藻酸盐及其制备方法和用途 |
CN1597703A (zh) * | 2004-08-20 | 2005-03-23 | 赵波 | 低分子海藻酸钾及其应用 |
CN103739740A (zh) * | 2013-11-30 | 2014-04-23 | 青岛海之林生物科技开发有限公司 | 海藻酸钾的制造方法 |
CN104222999A (zh) * | 2014-09-26 | 2014-12-24 | 大连雅威特生物技术股份有限公司 | 一种新型低钠盐的组成、制备和用途 |
Non-Patent Citations (2)
Title |
---|
余顺火等: "《食品 生物 生产实习教程》", 31 July 2016, 合肥工业大学出版社 * |
张万萍: "《水产品加工新技术》", 31 December 1995, 中国农业出版社 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110419712A (zh) * | 2019-08-03 | 2019-11-08 | 深圳震乾坤生物科技有限公司 | 低钾海带粉调胃低钠盐及制备方法和应用 |
CN110810804A (zh) * | 2019-12-30 | 2020-02-21 | 好当家集团有限公司 | 一种海带生物盐的制备方法 |
CN113875782A (zh) * | 2021-10-14 | 2022-01-04 | 中兆科生物科技(深圳)有限公司 | 一种灭杀新冠病毒外用喷雾剂 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101652143B (zh) | 用于选择性5-羟色胺再摄取抑制的组合物及其方法 | |
CN107149132A (zh) | 低钾海带粉排钠盐及制备方法和应用 | |
CN106074496A (zh) | 大麻酚类化合物在制备治疗痛风药物中的应用 | |
CN105997985A (zh) | 一种大麻提取物在制备治疗痛风药物中的应用 | |
CN110074243A (zh) | 一种具有解酒和保护肝脏功能的压片糖果 | |
EP1980258A1 (en) | Composition having effect of lowering blood pressure and/or inhibiting increase in blood pressure and food and drink containing the same | |
CN101433332B (zh) | 改善肠道功能润肠通便的食品补充剂及其制备方法 | |
CN112961262A (zh) | 一种西番莲果皮酸性多糖、制备方法及其应用 | |
CN115317574A (zh) | 一种用于治疗高尿酸血症的组合物及其应用 | |
CN109620948A (zh) | 高尿酸/痛风的全自然细胞调理方法 | |
CN105920198B (zh) | 一种具有补血功效的细胞破壁微粉及其制备方法 | |
CN106074464A (zh) | 大麻二酚在制备治疗痛风药物中的应用 | |
CN106389535A (zh) | 工业大麻火麻素在制备治疗痛风药物中的应用 | |
CN108245531B (zh) | 一种改善胃肠道功能、防治便秘的组合物 | |
JP3884611B2 (ja) | 衝動性疾患の改善剤 | |
CN107073032A (zh) | 肾衰竭发展抑制剂、肾衰竭预防剂及硫酸吲哚酚产生抑制剂 | |
CN101810679A (zh) | 多不饱和脂肪酸软胶囊及其制备方法 | |
CN110269897B (zh) | 一种抗疲劳和改善睡眠的组合物及其用途 | |
CN106720889A (zh) | 一种槟榔壳聚糖口香糖含片及其制备方法与应用 | |
JP2018188412A (ja) | 上部消化管粘膜吸収による副交感神経優位化リンパ球活性化上部消化管粘膜吸収抗腫瘍剤 | |
EP3943095A1 (en) | Traditional chinese medicine laxative composition for treating constipation, preparation method therefor and application thereof | |
EP2865278A1 (en) | Fat binder obtained from biomass resulting from beer production | |
CN109498762A (zh) | 一种预防治疗肥胖、高血压的组合物 | |
JP2006193501A (ja) | アディポネクチン調節剤、それを含有する飲食品、食品添加物及び医薬 | |
CN111265627B (zh) | 一种调节肠道菌群的海参多糖组合物及其制备方法和应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information |
Address after: 518000 1706, Block D, Jinlong Building, Guiyuan Street, Luohu District, Shenzhen, Guangdong Applicant after: Shenzhen Zhenqiankun Biotechnology Development Co.,Ltd. Address before: 518002 1706, Block D, Jinlong Building, Guiyuan Street, Luohu District, Shenzhen, Guangdong Applicant before: SHENZHEN ZHENQIANKUN BIOTECHNOLOGY CO.,LTD. |
|
CB02 | Change of applicant information | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20221110 Address after: Room 2401, Huale Building, No. 2017, Shennan East Road, Xinnan Community, Nanhu Street, Luohu District, Shenzhen, Guangdong 518000 Applicant after: Zhongzhaoke Biotechnology (Shenzhen) Co.,Ltd. Address before: 518000 1706, Block D, Jinlong Building, Guiyuan Street, Luohu District, Shenzhen, Guangdong Applicant before: Shenzhen Zhenqiankun Biotechnology Development Co.,Ltd. |
|
TA01 | Transfer of patent application right | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170912 |
|
RJ01 | Rejection of invention patent application after publication |